Document is current
Any future updates will be listed below
-
Authors
Tan, Sean https://orcid.org/0000-0002-2772-0695
Spear, Ella
Sane, Nikhita
Nelson, Adam J.
Nerlekar, Nitesh
Segelov, Eva
Nicholls, Stephen J.
- License Information
-
More Information
Article History
Received: 26 January 2023
Revised: 20 March 2023
Accepted: 6 April 2023
First Online: 19 April 2023
Competing interests
: SJN has received research support from AstraZeneca, Amgen, Anthera, CSL Behring, Cerenis, Eli Lilly, Esperion, Resverlogix, Novartis, InfraReDx, and Sanofi-Regeneron and is a consultant for Amgen, Akcea, AstraZeneca, Boehringer Ingelheim, CSL Behring, Eli Lilly, Esperion, Kowa, Merck, Takeda, Pfizer, Sanofi-Regeneron and Novo Nordisk. All other authors do not have any disclosures to declare.
: Ethical approval was granted for this study from the Monash Health Human Research Ethics Committee (RES-22-0000-158Q-85033). As this study was retrospective and observational in nature and no identifying information was obtained or reported, informed consent was not obtained from included study subjects.
